Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Fujisawa's new hypoglycemic and hypolipidemic agents

Feb. 26, 1999

Azacycloalkane derivatives for diabetes and related disorders patented by Synthelabo

Feb. 26, 1999

Growth factors shown to improve muscle healing in animal models

Feb. 26, 1999

AC-178335: new pure somatostatin antagonist that induces GH release in vivo

Feb. 25, 1999

Celtrix adds another patent to its SomatoKine portfolio

Feb. 25, 1999

Schein to introduce new product for management of hemodialysis patients with anemia

Feb. 24, 1999

Danish and Indian investigators disclose optically active nonsteroidal antiestrogens

Feb. 24, 1999

New obesity management drug approved in worldwide markets

Feb. 23, 1999

Raloxifene's effects on mood and cognitive function assessed

Feb. 23, 1999

Noven, Novartis and Vivelle Ventures to join in promoting osteoporosis nasal spray

Feb. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.